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A B S T R A C T
Background
Leber congenital amaurosis (LCA), a heterogeneous early-onset retinal dystrophy, accounts 
for —15% of inherited congenital blindness. One cause of LCA is loss of the enzyme 
lecithin:retinol acyl transferase (LRAT), which is required for regeneration of the visual 
photopigment in the retina.
Methods and Findings
An animal model of LCA, the Lrar'~  mouse, recapitulates clinical features of the human 
disease. Here, we report that two interventions— intraocular gene therapy and oral 
pharmacologic treatment with novel retinoid compounds— each restore retinal function to 
L r a C mice. Gene therapy using intraocular injection of recombinant adeno-associated virus 
carrying the Lrat gene successfully restored electroretinographic responses to —50% of wild- 
type levels (p < 0.05 versus wild-type and knockout controls), and pupillary light responses 
(PLRs) of Lrar'~  mice increased —2.5 log units (p < 0.05). Pharmacological intervention with 
orally administered pro-drugs 9-c/s-retinyl acetate and 9-c/s-retinyl succinate (which chemically 
bypass the LRAT-catalyzed step in chromophore regeneration) also caused long-lasting 
restoration of retinal function in LRAT-deficient mice and increased ERG response from —5% of 
wild-type levels in Lrar'~  mice to —50% of wild-type levels in treated Lrar'~  mice (p < 0.05 
versus wild-type and knockout controls). The interventions produced markedly increased levels 
of visual pigment from undetectable levels to 600 pmoles per eye in retinoid treated mice, and 
— 1,000-fold improvements in PLR and electroretinogram sensitivity. The techniques were 
complementary when combined.
Conclusion
Intraocular gene therapy and pharmacologic bypass provide highly effective and 
complementary means for restoring retinal function in this animal model of human hereditary 
blindness. These complementary methods offer hope of developing treatment to restore vision 
in humans with certain forms of hereditary congenital blindness.
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D evelopm ent o f  successful trea tm en ts  fo r in h e rited  and  
acqu ired  re tina l disease caused by gene m u ta tions rep resen ts  
a m ajo r challenge [1], Recessive congenital defects arising  
from  gene inactiva tion  and  subsequen t d is ru p tio n  o f  a 
m etabolic pathw ay a re  particu larly  am enable to  p h a rm aco ­
logical tre a tm en t o r  som atic gene therapy . O ral ad m in is tra ­
tion  o f  a p p ro p r ia te  com pounds can co rrec t visual deficits in 
hum ans and  o th e r  anim als by bypassing a b lock in the 
re tin o id  cycle [2], Sorsbv's fundus dystrophy  and  Leber 
co ngen ita l am aurosis (LCA) a re  two exam ples. Sorsbv's 
fundus dystrophy, an au to som al-dom inan t re tina l deg en er­
a tion  caused by m uta tions in the tissue in h ib ito r o f  the 
metalloproteinases-3 gene, leads to  n igh t b lindness [1], V itam in 
A (retinol [ROL]) ad m in is te red  orally  has been shown to 
significantly  re s to re  p h o to re c e p to r  fu n c tio n  in affec ted  
individuals [3], LCA is an early-onset recessive hum an re tina l 
d eg enera tion  th a t can  be  caused by m u ta tions in th e  gene 
en cod ing  re tin a l p igm en t ep ithe lium  65 (RPE65). a key 
p ro te in  involved in the p ro d u c tio n  and  recycling o f  11-m- 
re tin a l (11-cis-RAL) in th e  eye. A pprox im ate ly  15% o f 
p a tien ts  w ith LCA have been  found  to  have m u ta tions in 
Rpe65 pi.5], H um ans w ith this form  o f  LCA and  Rpe6.‘T l~ m ice 
bo th  have severely im paired  ro d  and  cone func tion  [6], T he 
b iochem ical block caused by the absence o f  Rpe6T '~  can be 
bypassed w ith synthetic m -re tin o id s  ad m in is te red  orally, 
re su ltin g  in  a d ram atic  im p ro v em en t in p h o to re c e p to r  
physiology [7],
Som atic gene therapy  has also been  very successful in m any 
anim al m odels o f  re tina l d eg enera tion  [8], Most notably, a 
c an ine  m odel w ith a na turally  o ccu rring  Rpe65 deficiency, 
th e  Rpe65~'~ dog. bears a p h eno type  sim ilar to th a t o f  hum an 
LCA pa tien ts  and  Rpe6.5~l~ m ice. A reco m b in an t adeno- 
assoc ia ted  v irus (rAAV) ca rry in g  w ild-tvpe (WT) Rpe.65 
(rAAV-Rpe65) re s to red  visual func tion  in this m odel o f  
ch ildhood  blindness ffl].
T he  le c ith in :re tin o l acyl tran sfe ra se  (L R A T )-deficient 
m ouse is an anim al m odel o f  LCA [10], M utations in the 
gene encod ing  I,RAT are  associated w ith early-onset severe 
re tin a l dystrophy, o r  LCA Til]. T he p revalence o f  m uta tions 
at this locus am ong p a tien ts  w ith LCA is unknow n bu t it is 
likely uncom m on, as th ree  o f  267 p ro b an d s w ith severe early- 
onset re tina l dystrophy  ca rried  m u ta tions in Lrat [11], I,RAT 
is a key enzym e involved in sto rage o f  ROL in th e  form  o f 
retiny l esters (REs) in specific s tru c tu res  know n as re tino - 
som es [12], W ithou t I,RAT. no  11-cis-RAL ch ro m o p h o re  is 
p roduced , and  visual func tion  is severely im paired  [10],
H ere, we aim ed to  investigate w h eth er we could  rescue 
visual func tion  by pharm acological in te rv en tio n  and  gene 
tran sfe r therapy  in LRA T-deficient mice, and  to  assess the 
advantages and  d isadvantages o f  o ra l ad m in is tra tio n  o f  
re tin o id s  an d  gene  th e rap y . C o m p ariso n  o f  these  two 
app roaches is an im p o rtan t p re lu d e  fo r tre a tm en t in hum ans.
Methods
Animals
All anim al experim en ts em ployed p rocedu res  app roved  by 
th e  U niversity o f  W ashington and  co n fo rm ed  to  reco m m en ­
da tions o f  the A m erican V eterinary  M edical Association 
Panel on E uthanasia and  recom m endations o f  th e  Associa­
I n t r o d u c t i o n tion  o f  R esearch fo r Vision and  O phthalm ology. Animals 
w ere m ain ta in ed  in com plete  darkness, and  all m an ipu la tions 
w ere done  u n d e r dim  red  light em ploying a K odak No. 1 
safelight filte r (tran sm ittance  >  560 nm). Lra(~'~ m ice w ere 
g e n e ra te d  an d  g en o tv p ed  as d e sc rib ed  p rev iously  [10], 
Typically. 6- to 12-wk-old m ice w ere used in all experim en ts. 
In th e  case o f  rAAV-Lrat trea tm en t. 2- to  3-wk-old m ice w ere 
used.
rAAV1-VMD2-mLraf Vector
T he pT R -l!F5 backbone [13] was used fo r  g enera tion  o f a 
pTR-VM I)2-m LRAT plasm id construc t. An E coR l fragm ent 
co n ta in in g  th e  fu ll-length  m ouse Lrat cDNA was excised from  
pC R-TO PO  II B lunt-Lm f and  b lu n t ligated  in to  th e  N o tl site 
o f  th e  UF5 cassette, rep lac ing  th e  Gfp gene. O rien ta tio n  o f the 
cDNA was confirm ed  by res tric tio n  analysis and  by sequenc­
ing. T he K p n l-X b a l fragm ent o f  the placF-VM D2 plasm id 
(from  I). Zack. Jo h n s  H opkins U niversity) f 14] includes the 
-585/4-38 u p s tre a m  reg io n  o f  th e  h u m an  VMD2 gene 
(C hrom osom e l l q l3 )  and  was subcloned  in to  the K p n l- 
X bal sites o f  the  pT R -l!F5 cassette (replacing the CMV 
p ro m o te r) upstream  o f  m ouse Lrat cDNA. Sequence analysis 
confirm ed  th e  o rien ta tio n  and  read ing  fram e o f  the Lrat 
cDNA. A sero type  1 AAV vec to r was p ro d u ced  in the 
p resence  o f  a m ini-A d he lp e r p lasm id pI)G 38 by doub le  
tran sfec tion  o f  HEK2S3 cells, follow ed first by purifica tion  
over an iodixanol g rad ien t and  then  by h igh-Q  FPLC colum n 
ch rom atog raphy  (Pharm acia. U ppsala. Sweden). V ector p a r ­
ticle tite rs  w ere d e te rm in ed  by q u an tita tive  PCR. T he rA A V l- 
VM I)2-mLmf vec to r was p re p a re d  at 4 X 10Ll physical 
particles/m l. Exclusive RPE expression  is seen in m ice using 
a Gfp r e p o r te r  gene in an analogous rA AV l-VM I)2 vecto r 
(Glushakova and  H ausw irth . unpub lished  data).
Preparation of Retinoids and Oral Gavage
All-fmns-retinyl ace ta te  (R-Ac). all-fmns-R-Palm. all-fmns- 
RAL. all-fmas-ROL. and  9-m -RAL w ere p u rch ased  from  
Sigm a-A ldrich (St. Louis. M issouri. U n ited  States). fl-eis-ROL. 
fl-eis-R-Palm. 9-ds-R-Ac. and  9-m -retinyl succinate  (fl-eis-R-Su) 
w ere p re p a re d  from  fl-m-RA I T o  p re p a re  9-m-R-Ac. 100 mg 
o f  fl-m-RAL was reduced  w ith 50 m g o f  sodium  b o rohyd ride  
in 0.7 ml o f e thano l at 0 °C fo r 30 m in. and  fl-eis-ROL was 
purified  by o rgan ic  ex trac tio n  and  d ried  u n d e r argon. Solid 
9-cu-RO l, an d  80 m g o f  4 -d im e th y lam in o p v rid in e  w ere 
dissolved in 0.4 ml o f  d ry  CH*>CU and  0.1 ml o f  acetic acid 
anhyd ride  was added. A fter 6 h at 10 °C. th e  reac tion  was 
q uenched  w ith 0.1 ml o f  e thanol. CH*>CU> was rem oved by 
flowing argon  at 20 °C. and  fl-eis-R-Ac was purified  by organ ic  
ex trac tion  and  d ried  u n d e r  argon. T o p re p a re  all-fmns-R-Su 
o r  fl-eis-R-Su. solid all-fmns-ROL o r  9-m -R O L was dissolved in
0.2 ml o f  pyrid ine, w ith 100 m g o f  succinic acid anhydride  
added  and  reac ted  overn igh t at 10 °C. CH*_>CU was rem oved by 
flowing argon  at 20 °C. and  all-fmns-R-Su o r  fl-eis-R-Su was 
then  purified  by organ ic  ex trac tion  and  d ried  dow n u n d e r 
argon. R etino ids w ere dissolved in p u re  canola oil (W estern 
Family Foods. T igard. O regon . U n ited  States), and  co n cen ­
tra tio n s w ere m easured  spectropho tom etrica lly . R etino ids at 
a final c o n c e n tra tio n  o f  40 mg/ml in cano la  oil w ere 
ad m in is te red  to  Lrar'~  m ice using a 1-ml syringe and  a 20- 
gauge. 3.5-cm long gavage needle . Mice w ere allowed to  rest 
fo r 3 d  follow ing gavage. A single 5-mg dose (125 j.il) o f 
re tin o id  was used to com pare  th e  d iffe ren t re tino ids. Doses o f
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gavaged 9-m-R-Ac w ere 1, 2, 5, 10, 20, and  40 (.imoi to  
d e te rm in e  dose effect. M ultiple gavages o f  9-m -R-Ac w ere 
pe rfo rm ed  w ith doses o f  1, 5, and  10 (.imoi fo r up  to ten 
consecutive trea tm en ts.
Photobleaching of 9-c/s-R-Ac Gavaged Mice
I.rat m ice w ere gavaged fo u r tim es w ith 10 (.imoi doses o f 
9-m -R-A c. C aged m ice w ere p laced  on a b en ch  u n d e r 
fluo rescen t light o f  average lum inosity  600 cd X m " and  
allowed to p ho tob leach  fo r 1, 3, and  10 d. Mice w ere then  
placed in th e  dark  fo r 1 d, sacrificed, and  the eyes collected 
fo r re tin o id  analysis. A subset o f  m ice w ere gavaged w ith 10 
(.imoi 9-m -R-A c follow ing pho tob leach , p laced in the dark  fo r
I d, sacrificed, and  th e  eyes co llected  fo r re tin o id  analysis.
Pupillary Light Responses
Pupillary  light responses (PLRs) w ere reco rded  from  dark- 
adap ted  m ice u n d e r in fra red  cond itions using a CCI) video 
cam era  fitted  w ith  close-up lens and  an IR filter. D ata analysis 
was p e rfo rm ed  by video pupillom etry . L ight stim uli w ere 
p rov ided  by a halogen source; w avelength and  in tensity  w ere 
m an ipu la ted  w ith neu tra l density  and  narrow  bandw id th  (10 
nm ) in te rfe ren ce  filters (O riel, S tra tfo rd , C onnecticu t, U nited  
States). Irrad iance  m easurem en ts (W /nr) w ere m ade using a 
rad io m e te r (A dvanced Pho ton ics In te rna tiona l, W hite Plains, 
New York, U n ited  States).
Analyses of Retinoids and Visual Pigments
All p ro ced u res  w ere p e rfo rm ed  u n d e r  dim  red  light as 
described  previously |7,15,16|. R etino id  analysis was p e r­
fo rm ed  on an A gilent 1100 series HPLC eq u ip p ed  w ith a 
d io d e  a rray  d e te c to r  an d  A gilen t C h em sta tio n  A. 10.01 
softw are (Agilent, Palo Alto, C alifornia, U n ited  States). A 
norm al phase colum n (Beckman U ltrasphere  Si 5|i, 4.6 X 250 
m m  IBeckman Instrum ents, Fullerton , C alifornia, U nited  
S tates|) and  an isocratic solvent system o f 0.5% ethyl ace tate  
in hexane (v/v) fo r 15 m in follow ed by 4%  ethyl ace ta te  in 
h exane fo r 65 m in at a flow ra te  o f  1.4 m l/m in at 20 °C (total 
80 m in) w ith d e tec tion  at 325 nm  w ere used.
All o f  the experim en ta l p ro ced u res  re la ted  to  the analysis 
o f  dissected m ouse eyes, derivatization , and  separa tion  o f 
re tino id s have been  described  previously |7 |. R hodopsin  and 
iso rhodopsin  m easurem en ts w ere pe rfo rm ed  as described 
previously 117|. Typically, two m ouse eyes w ere used p e r  assay, 
and  th e  assays w ere rep ea ted  th ree  to  six tim es. W hole livers 
w ere hom ogenized  fo r 30 s in 4 ml o f  re tin o id  derivatization  
b u ffe r (50 mM MOPS, 10 mM X I  l>( ) II,  and  50% ethano l in
II >() |pH  7 .01) using a Poly tron  PT1200 m oto rized  hom oge­
nize!' (Polytron, Bad W ildbad, G erm any), and  allowed to  sit at 
ro o m  te m p e ra tu re  fo r  30 m in . R e tin o id  analysis was 
pe rfo rm ed  on 1 ml o f liver hom ogenate  follow ing th e  same 
e x tra c tio n  p ro c e d u re  used  fo r  eyes. M ouse b lo o d  was 
co llected  from  th e  eye socket using h ep arin ized  m icro ­
h em ato c rit capillary  tubes (F isher Scientific) im m ediately 
follow ing rem oval o f  the eyes. B lood was tran sfe rred  to  a 
ta re d  1.5-ml K p p endo rf tu b e  and  w eighed (K ppendorf, 
H am burg, G erm any). N ext, 1 ml o f  re tin o id  derivatization  
bu ffe r was added  and  vortexed  (K ppendorf M ixer 5432) fo r 30 
m in h igh speed at room  tem p era tu re . B lood was then  used fo r 
re tin o id  analysis follow ing the sam e ex trac tion  p ro ced u re  
used fo r eyes. R hodopsin  from  l.rai m ice tre a ted  w ith
l'AAV-l.mt virus was isolated by im m unoaffin ity  ch rom atog ­
raphy  as described  previously 118|.
Electroretinography
Mice w ere anesthetized  by in trap e rito n ea l in jection  using 
20 |.il/g body w eight o f  6 mg/ml ketam ine  and  0.44 mg/ml 
xylazine d ilu ted  w ith  10 mM sodium  pho sp h a te  (pH 7.2), 
co n ta in in g  100 mM NaCl. T he  pupils w ere d ila ted  w ith \%  
trop icam ide. A con tac t lens e lec trode  was placed on the eye, 
and  g round  elec trodes w ere p laced on th e  scalp and  tail. 
K lectroretinogram s (KRGs) w ere reco rd ed  w ith the universal 
testing  and  electrophysiologic system UTAS K-3000 (LKC 
T echnologies, G aithersburg , M aryland, U n ited  States). T he 
light in tensity  was ca lib ra ted  and  co m pu ter-con tro lled . T he 
m ice w ere p laced in a G anzfeld cham ber, and  scotopic 
responses to  flash stim uli w ere o b ta ined  from  b o th  eyes 
sim ultaneously. Flash stim uli had  a range o f  in tensities (—3.7 
to  2.8 log cd-s-m "’), and  w hite light flash d u ra tio n  was 
ad justed  accord ing  to  in tensity  (from  20 (.is to  1 ms). T h ree  to 
five record ings w ere m ade w ith intervals o f 10 s o r  longer, and 
fo r h ig h e r in tensity  trials, in tervals w ere 10 m in o r  as 
ind icated . Five anim als w ere typically used fo r reco rd in g  o f 
each p o in t in gavage conditions. KRGs w ere pe rfo rm ed  on all 
m ice tre a ted  w ith rAAV-l.mt. T he results w ere exam ined  
using the one-way ANOVA test.
Recordings from Rods
Suction  e lec tro d e  record ings from  ro d  p h o to recep to rs  
follow ed published  p ro ced u res 1191. In brief, a small p iece o f 
re tin a  was sh redded  w ith fine needles, and  the resu lting  
suspension was p laced in a ch am b e r on th e  m icroscope stage. 
Single o u te r  segm ents w ere draw n by suction  in to  a tightly 
fitting  glass e lec trode , and  changes in o u te r  segm ent cu rren t 
in re sp o n se  to  b r ie f  ligh t flashes w ere  m easu red . All 
p ro ced u res  w ere ca rried  o u t using in fra red  illum ination  
(>950 nm). Mice fo r these experim en ts w ere dark  ad ap ted  fo r 
at least 12 h. C57B1/6J m ice w ere used as contro ls. All 
experim en ts w ere carried  ou t at 35 -37  °C.
Liver RA Analysis
T he m ethod  o f  Kane et al. was used w ith slight varia tion  
1201. W hole m ouse livers w ere rem oved from  I.rat m ice 
a f te r  eye rem oval d u rin g  the  above experim en ts. Livers w ere 
w eighed and  then  frozen in liquid  N*_>. Frozen livers w ere 
tran sfe rred  to  a 15-ml glass cen trifuge  tu b e  (Corex #8 1 11 
IC orn ing  Life Sciences, A cton, M assachusetts, U n ited  States|) 
co n ta in in g  ice-cold p h o sp h a te  bu ffe red  saline (PBS) at a 1:4 
ra tio  o f  liver to  PBS (w/v) to  m ake a 25% hom ogenate  and 
w ere hom ogenized  30 s using a Poly tron  PT1200 m otorized  
hom ogenize!'. N ext, 500 |.il o f  h om ogena te  was tran sfe rred  to 
an 8-ml glass tu b e  on ice, and  1 ml o f  ice-cold e thano l and  5 |.il 
o f  5 M N aO H  w ere added  and  vortexed. Finally, 4 ml o f  ice- 
cold hexane was added, and  th e  m ix tu re  was vortexed  and 
cen trifuged  fo r 5 m in using a B eckm an J2-HS cen trifuge  w ith 
a JS 1 3 .1 sw inging bucket ro to r  fo r 5 m in at 4,000 rpm , 4 °C. 
T he hexane layer was rem oved and  discarded . T he hexane 
ex trac tion  was rep ea ted  one  m ore  tim e. T o ex trac t RA, 20 |.il 
o f  12 M HC1 was added  to  the rem ain ing  aqueous solu tion  
and  vortexed. H exane ex trac tion  was p e rfo rm ed  as above, bu t 
hexane was re ta in ed  from  b o th  ex trac tions and  d ried  down 
u n d e r  blow ing argon at 20 °C. Residue was dissolved in 300 |.il
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o f 1,000:4.3:0.675 hexane:2-propanol:acetic  acid  (v/v) and  
tran sfe rred  to  an am b er glass HPLC vial w ith glass insert.
F or the first separa tion , 100 |.il o f  sam ple was in jec ted  in to  
th e  A gilent 1 100 HPLC described  above. Two tandem  norm al 
phase colum ns w ere used. T he first colum n was a V arian  
M icrosorb  Silica 3|i, 4.6 X 100 mm colum n (V arian, Palo Alto, 
C alifornia, U n ited  States), and  th e  second was the Beckm an 
colum n described  above. A n isocratic solvent system o f 
1,000:4.3:0.675 hexane:2-propanol:g lacial acetic acid (v/v) at 
a flow ra te  o f 1 ml/m in at 20 °C w ith d e tec tio n  at 355 nm  was 
used [211. T he system was ca lib ra ted  using  standards o f all- 
trtins-RA  and  9-ei.v-RA pu rchased  from  Sigm a-A ldrich.
Immunocytochemistry and Histology
Procedures have been described  previously [221. A nti- 
1,RAT m onoclonal an tibody  [101 was d irectly  coup led  w ith 
A lexa488, o r  de tec ted  by an ti-m ouse IgG labeled  w ith Cy3. 
Sections w ere analyzed u n d e r  an ep ifluorescence m icroscope 
(N ikon, Tokyo, Jap an ). Low m agn ifica tion  im ages w ere 
c ap tu red  w ith a d ig ita l cam era  (ORCA-KR, H am am atsu  
Photonics, B ridgew ater, New Jersey, U n ited  States) o r  a Zeiss 
LSM 510 NLO confocal m icroscope (Zeiss, O berkochen , 
G erm any).
R etinas o f 17-m o-old I.m l and  WT m ice w ere m arked, 
enuclea ted , and  im m ersed im m ediately  in a fixative o f  4% 
p a ra fo rm a ld eh y d e  in 0.1 M p h o sp h a te  b u ffe r (pH 7.4). 
Following fixation fo r 4 -5  h at 4 °C, the eyecup con ta in ing  
th e  op tic  nerve was postfixed in \%  osm ium  te tro x id e  in 
pho sp h a te  buffer, d ehyd ra ted  th rough  a series o f  g raded  
e thano l, and  em bedded  in S p u rr 's  resin . Sections 0.5-1 |.im 
thick w ere im aged using a Leica (W etzlar, G erm any) DM-R 
m icroscope w ith P rio r stage, using Syncroscan RT softw are 
from  Syncroscopy (Frederick, M aryland, U n ited  States). T he 
scaling fo r m easu rem en t is 182 nm /pixel and  5.5 pixels/ 
m ic ro m ete r at 40X. T he thicknesses o f ro d  o u te r  segm ents 
(ROSs) in m icrom eters as a func tion  o f d is tance  from  the
O NH  w ere m easu red  a f te r  im p o rt in to  D eneba Canvas 
softw are (ACT) Systems, S aanich ton , B ritish C olum bia, C an ­
ada).
Transmission EM
For transm ission  e lec tro n  m icroscopy (KM), m ouse eyecups 
w ere fixed prim arily  by im m ersion  in 2.5% glutaraldehyde 
and  1.6% p arafo rm aldehyde  in 0.08 M PIP KS (pH 7.4) 
co n ta in in g  2% sucrose, initially  at room  tem p e ra tu re  fo r 
~  1 h, then  at 4 °C fo r the  rem a in d e r o f  24 h. T he eyecups 
w ere then  w ashed w ith 0.13 M sodium  pho sp h a te  (pH 7.3), 
and  secondarily  fixed w ith \%  ( ) s ( ) ( in 0.1 M sodium  
pho sp h a te  (pH 7.4), fo r 1 h at room  tem p era tu re . T he 
eyecups w ere deh y d ra ted  th rough  a C H 3OH series and  
tran s itio n ed  to  the epoxy em bedd ing  m edium  w ith p ropy lene  
oxide. T he eyecups w ere em bedded  fo r section ing  in Kponate 
812. U ltra th in  sections (60-70 nm ) w ere sta ined  w ith aqueous 
sa tu ra ted  u ran iu m  aceta te  and  R eynold’s fo rm ula  lead  c itra te  
p r io r  to survey and  m icrography  w ith a Philips CM 10 KM 
(Philips Klectron O ptics, Kindhoven, T he N etherlands).
Statistical Analyses
D ata w ere expressed  as m ean ±  stan d ard  e r ro r  o f  the  m ean 
(SKM) Liver da ta  was p resen ted  as m ean  ±  SKM o f one- 
q u a r te r  o f w hole livers. B lood data  was p resen ted  as m ean  ±  
SKM p e r  100 m g o f blood.
Results
L ra t1 Mice Are a Model of Vitamin A Deficiency
We analyzed th e  re tin o id  co n ten t o f I .r a t1 and  l.r til'h "m ice 
to d e te rm in e  how th e  absence o f  I,RAT influenced  th e  levels 
o f  the 1 1-a.v-RAL ch ro m o p h o re  and  its derivatives. I.ml 
m ice had d im in ished  levels o f all-/m av-retinoids in th e  eye 
[101 and  100- to 1,000-fold low er levels o f  eis-retinoids 
com pared  w ith WT m ice (Figure SI). 6w -retino ids w ere also
Table 1. Retinoid Analysis of Tissues from Lra t1 Mice Gavaged with 20 (.imol 9-ris-R-Ac as a Function of Post-Treatment Time
Organ Com pound Recovery Time
L ra t '-  Lrat+/+ No
Treatment
O h  2 h 5 h 10 h 24 h 48 h 72 h 96 h
pmol SD  pmol SD  pmol SD  pmol SD  pmol SD  pmol SD  pmol SD  pmol SD  pmol SD
Blood REs 1.0 1.7 235.3 205.4 33.7 58.5 6.6 1.6 10.9 6.7 1.2 2.2 0.7 1.2 0.4 0.8 8.3 6.3
9-c/s-R-Ac 0.0 0.0 24.0 27.4 4.1 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0
9-c/s-Retinal oximes 0.0 0.0 366 275.7 87.6 51.5 28.8 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0
9-c/s-Retinol 0.0 0.0 86.8 60.1 11.1 19.1 2.9 0.4 0.0 0.0 6.1 10.5 2.1 3.6 0.0 0.0 0 0
All-frans-retinol 6.2 3.0 35.6 25.2 6.0 10.2 2.2 0.4 6.4 11.0 3.5 6.1 10.1 3.6 2.6 4.4 13.3 8.5
Liver REs 18.2 6.5 3,509.9 1,773.3 5,169.0 1,729.9 1,509.6 165.8 348.8 119.1 79.8 28.7 64.2 22.9 64.2 12.9 4.3 X 105 4.7 X '
9-c/s-R~Ac 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0
9-c/s-Retinal oximes 0.0 0.0 5,390.7 3,678.3 9,656.4 6,105.6 894.3 25.8 53.4 92.4 6.3 10.8 0.0 0.0 26.1 4.2 0 0
9-c/s-Retinol 0.0 0.0 1,601.4 1,491.6 2,148.6 1,875.4 277.8 35.6 39.0 67.5 39.0 28.7 15.7 9.5 13.6 2.4 0 0
All-frans-retinol 147.8 18.8 1,341.0 1,182.1 2,052.2 1,753.3 884.2 61.1 401.0 694.7 253.4 2.4 218.9 106.3 310.9 65 635.8 138.1
Eye REs 1.1 0.5 8.8 0.5 19.2 14.4 3.2 5.5 20.2 10.8 4.6 4.2 0.9 0.9 3.2 0.2 97.8 30.2
9-c/s-R-Ac 0.0 0.0 0.6 1.0 4.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0
9-c/s-Retinal oximes 0.0 0.0 108.0 39.9 300.0 35.2 351.0 15.7 328.6 57.7 299.2 51.0 334.8 35.5 371.5 5.2 3.7 0.36
9-c/s-Retinol 0.0 0.0 50.6 10.2 76.1 34.9 36.6 3.9 17.3 14.3 6.2 5.2 3.1 3.4 0.0 0.0 0 0
All-frans-retinol 8.9 1.5 25.3 6.6 46.1 13.4 35.2 2.5 25.5 10.1 17.4 2.2 12.5 1.4 15.7 4.4 13.5 0.7
Retinoids were analyzed by HPLC as described in Methods. The amounts are expressed per liver, eye, and 100 mg of blood. 
DOi: 10.1371/journal.pmed.0020333.t001
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Figure 1. Retinoid Structures, Specificity of Retinoids in Regeneration of Visual Pigment, and Model of Absorption of 9-ds-R-Ac in Mammals
(A) Structures of retinoids used for gavage studies.
(B) Levels of all-frans-RAL oximes, 9-ds-RAL oximes (corresponding to formation of visual pigment isorhodopsin), and all-frans-REs in LraC1" mouse eyes 
gavaged with 5 mg of each retinoid before 48-72 h dark adaptation (n > 3, data shown with standard deviation [SD]).
(C) Model of absorption of 9-ds-R-Ac in mammals.
DOI: 10.1371/journal.pmed.0020333.g001
observed in /i/«65-defieien t m ice, bu t at 5% o f  th e  level o f 
W T m ice [23], F orm ation  o f  cis-retinoids is likely due  to the 
p ro p en s ity  o f  re tin o id s  to  spon taneously  isom erize and  
becom e tra p p e d  by opsin in the ph o to recep to rs , l.m t is 
expressed  in th e  liver as well as in the eye; th e  am o u n t o f  REs 
in the liver o f  l . r n f1 m ice was m ore  than  20,000-fold low er 
than  W T m ice (Table 1). C ircu la ting  all-ftvms-ROL from  the 
d ie t was also reduced , p rod u c in g  low er re tin o id  co n cen ­
tra tio n s  in th e  b lood (Table 1). No visual p igm ents w ere 
m easurab le  in the  l . r n f1 m ice by d irec t spec tro p h o to m etric  
analysis.
Visual Pigment in Lraf-Deficient Mice Is Restored by Oral 
Gavage with 9-c/s-Retinoid
W e syn thesized  a series o f  fl-c /s-retino ids a n d  e s te r  
derivatives to  d e te rm in e  w h eth er the ph en o ty p e  o f  l . r n f1 
m ice could  be reversed by chem ically bypassing the LRAT- 
catalyzed m etabolic  step  (Figure 1A). O ral gavage o f  these 
exogenous re tino id s led to  th e  genera tion  o f  visual p igm ent 
in l . r n f1 m ice. Visual p igm ents w ere m easured  ch rom ato - 
graphicallv  by the  re ten tio n  o f  fl-e/.s-RAL oxim es (Figure IB) 
o r  spec tropho tom etrica lly  (unpublished  data) by the level o f 
iso rhodopsin  (i.e., opsin  +  fl-e/.s-RAL ch rom ophore). B oth 
m ethods w ere highly rep ro d u c ib le  and  yielded sim ilar results. 
Visual p igm ent was rescued  in l . r n f1 m ice by oral gavage 
w ith  fl-cis-RE, 9-cAs-RAL, o r  9-c«-R()L , w hereas all-ftrm.s 
isom ers w ere ineffective. A m ong REs, fl-cis-R-Ac an d  fl-cis-R- 
Su w ere m ost efficient (by w eight p e r  dose) in res to ring  
p igm ent (Figure IB). Esters a re  readily  m etabolized  in the 
small in testine  an d  a re  m ore  in e rt than  RALs and  ROLs
(Figure 1C). F o r these reasons fl-cis-R-Ac was chosen fo r the 
rem ain ing  experim ents.
Kinetics of Visual Pigment Rescue and Retinoid Clearance 
by Oral 9-c/s-R-Ac in Lraf-Deficient Mice
(ravage w ith fl-cis-R-Ac p ro d u ced  a tran s ien t increase in 
re tin o id  levels in th e  liver and  a m ore  sustained  increase in 
levels in th e  eye (Figure 2). T he visual p igm en t was re s to red  in 
l . r n f1 m ice 4 -5  h a f te r  gavage w ith fl-eu-R-Ac. Visual 
p igm ent levels m easu red  by HPLC rem ained  nearly  constan t 
fo r  flfi h (Figure 2G). By 120 d follow ing a single oral gavage 
w ith fl-cis-R-Ac, d a rk -rea red  l . m t 1 m ice re ta in ed  m ore  than  
50% o f  th e  p igm ent (Figure 2H). C onsidering  th a t —10% o f 
ROSs a re  phagocytosed daily an d  rep laced  by newly fo rm ed  
discs at th e ir  base [241, these data  suggest th a t even in the 
absence  o f  LRAT, th e  ch ro m o p h o re  m ay be efficiently  
recycled  via hydrolysis o f  iso rh o d o p sin  an d  d irec tio n a l 
tra n sp o rt o f  fl-cis-RAL from  th e  RPE to the p h o to recep to rs .
D espite th e  absence o f  LRAT, REs w ere fo rm ed  transien tly  
in th e  liver and  b lood  a f te r  gavage, suggesting th a t a n o th e r 
enzym e is capable  o f  the esterification  reaction , such as acyl 
coenzym e A:diacylglvcerol acy ltransferase [251. In ' ess than  10 
h, m ore  than  90% o f re tino ids, includ ing  n uc lea r re cep to r 
activators all-ftvms-RA an d  9-ds-RA, w ere cleared  (Figure 21 
and  2J; T able 1). T hus w ith in  4 -5  h a fte r  gavage, p erip h era l 
hydrolysis o f  REs is fas te r th an  synthesis, and  re tino id s are  
quickly m etabolized  o r  secreted . These data  suggest efficient 
up take  o f  9-cis-retinoids by th e  visual p igm en t and  rap id  
c lea rance o f  excess exogenous re tino id s from  key m etaboliz­
ing an d  tra n sp o rtin g  tissues, low ering th e  po ten tia l fo r 
toxicity.
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Figure 2. Retinoids in the Liver and Eyes of Lrat ' Mice after 9-cis-R-Ac Treatment
(A-F) Normal-phase HPLC analysis of nonpolar retinoids extracted from the tissues of dark-adapted Lrat1' 1 or Lrat ' mice following gavage with 
retinoids. Peaks marked * represent the solvent change artifact, and peaks labeled (1) indicate an unidentified non-specific compound with ?.ma>r- 270 
nm. In all experiments, mice were dark-adapted for 48 h after gavage. Shown are results from eyes of dark-adapted control Lrat1' 1 (gray) and Lrat' 
mice (black) (A); eyes of dark-adapted Lrat ' mouse gavaged with all-frans-R-Ac (B); eyes of dark-adapted Lrat ' mouse gavaged with 9-cis-R-Ac (C); 
liver tissue from dark-adapted control Lrat1' 1 (gray) and Lrat ' (black) mice (D); liver tissue from dark-adapted Lrat ' mouse gavaged with all-frans-R- 
Ac (E); and liver tissue from dark-adapted Lrat ' mouse gavaged with 9-cis-R-Ac (F).
(G-J) Time course of the levels of nonpolar and polar retinoids in the tissues of Lrat' mice following gavage with 9-cis-R-Ac measured by HPLC. After 
gavage, mice were dark adapted for indicated time before HPLC analysis (n > 3, data shown with SD). The graphs depict: a short time course of 9-cis- 
RAL oxime levels detected in Lrat ' mice eyes following a 20 nmol gavage of 9-cis-R-Ac (G); a longer time course of 9-cis-RAL oxime levels in Lrat ' 
mice eyes following a 20 pmol gavage of 9-cis-R-Ac (H); time course of 9-cis-ROL blood levels in Lrat' mice following gavage with 20 nmol 9-cis-R-Ac 
(I); and time course of RE and RA levels in liver of Lrat' mice following a 20 pmol gavage with 9-cis-R-Ac (J).
DOI: 10.1371/journal.pmed.0020333.g002
Regeneration of Visual Pigments Improves the 
Morphology of Rod Photoreceptors
M aximal visual p igm en t fo rm atio n  req u ired  ~ 4  |.lmol o f  9- 
cis-R-Ac (Figure 3A). T he level o f  iso rhodopsin  in  the eye o f 
l . r n f 1 m ice a f te r  a single gavage was ~ 6 0 % -7 0 %  o f the WT 
level o f rh o d o p sin  (Figure 3). W hen to ta l opsin  was isolated by 
im m u n o a ff in ity  c h ro m a to g ra p h y , th e  UV-vis sp e c tru m  
show ed th a t all opsin  p resen t in  the re tin a  was regenera ted  
(unpublished  data), suggesting th a t all opsin  was p ro p erly  
fo lded  bu t is p resen t in  ROS at low er am oun ts th an  in  WT 
ROS. M ultip le 5- to  10-|.lmol doses sp read  o v er weeks 
p ro d u ced  alm ost full recovery  o f WT levels o f visual p igm ent 
(Figure 311).
E xposure to  light released the isom erized  ch ro m o p h o re  as 
all-ftvms-ROL in tre a ted  /.rrtf-deficient m ice (Figure 3C, black) 
w ith kinetics p ro p o r tio n a l to  the in tensity  o f  the b leaching 
light. Subsequent gavages re s to red  the ch ro m o p h o re  effi­
c iently  (Figure 3C, red). M ultiple gavages were effective in 
m ice u p  to  12 m o o ld  (Figure S2A). H istological analysis 
show ed th a t the re tin a  o f u n tre a te d  l .r n f ' m ice degenera ted  
slowly (Figure S2B), leaving functionally  in tac t p h o to re c e p ­
to rs available fo r  tre a tm en t in the o ld e r mice.
Since ROS s tru c tu ra l m orphology  is though t to be d ep en d ­
en t on  func tiona l rhodopsin , this result (in co n ju n c tio n  w ith 
recycling o f  the ch ro m o p h o re  as discussed above) suggested 
tha t ROS m orphology  m ight be im proved  w ith trea tm en t. We 
used EM to evaluate the RPE-ROS in terface . C on tro l and  
gavaged /.rrtf-deficient m ice w ere analyzed. T he thickness o f 
the ROS layer was substantially  im proved, from  10.7 ±  0.1 fi 
|.im to  14.2 ±  2.2 |.im in  tre a ted  mice, and  the RPE-ROS 
in terface  showed c loser apposition  in  com parab le  areas o f 
the re tin a  (Figure 3D and  3E; n =  5, p  <  0.002).
Improvement of Rod Responses in L r a r Mice Treated 
with 9-c/s-R-Ac
O u te r  segm ent m em brane cu rren ts  o f  l . r n f '  and  l . r n f1 
rods w ere d irectly  m easured  w ith suction  e lec trodes (Figure 
4). Rods o f  u n tre a te d  l . r n f ' m ice w ere ~ 2,000-fold  less 
sensitive than  l .r n f '  rods. Gavage o f l . r n f1 m ice w ith 9-cis-R- 
Ac re s to red  near-W T  sensitivity, a lthough  several trea tm en ts  
w ere requ ired .
Figure 4A and  4B show flash fam ilies re co rd ed  from  l . r n f ' 
and  l . r n f 1 rods, l . r n f1 rods had  a sm aller dark  c u rre n t than
l.rnf rods (m ean ±  SEM: l.rnf , 4.8 ±  0.4 pA, «  =  21; l.rnf ,
15 ±  1 pA, n =  22). In add ition , the dim  flash response 
reached  a peak m ore quickly in l . r n f1 rods ( l .r n f ' \  108 ±  4 
msec; l.rnf , 228 ±  9 msec). Sensitivity was estim ated  by
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Figure 3. Levels of 9-ci's-RAL Oximes in the Eyes of Lrat ' Mice after a Single or Multiple Dose of 9-ci's-R-Ac
(A) The level of 9-cis-RAL in L r a C mouse eyes after a varying dose of 9-cis-R-Ac.
(B) The level of 9-ci's-RAL in Lrat~/~ mouse eyes after a varying size and number of doses of 9-cis-R-Ac. The solid gray line represents a maximal level of 
isorhodopsin as measured by the level of 9-cis-retinal oximes in Lrat~/~ mouse eyes after ten gavages; dashed gray line indicates the SD. The maximal 
level of isorhodopsin is comparable to the level of rhodopsin in WT mice (blue dotted line, shown as pmol of 11-ci's-retinal/eye).
(C) The level of 9-ci's-RAL in L r a r mouse eyes after 9-cis-R-Ac treatment and light exposure or after exposure to light and re-gavage (n > 3, data shown 
with SD).
(D and E) Changes in the RPE-ROS interface in control Lrat~/~ mice and L r a C mice treated with 9-cis-R-Ac. Treated Lrat~,~ mice were gavaged with 9- 
ci's-R-Ac (10 nmol per gavage) six times, 3 d apart, and analyzed (D). Control retina from age-matched (8 wk old) untreated Lrat~,~ mice (E). Considerably 
improved RPE-ROS processes were observed in all treated mice. RPE, retinal pigment epithelium; ROS, rod outer segments; IS, inner segments. Scale bar,
10 nm.
DOI: 10.1371/journal.pmed.0020333.g003
p lo ttin g  the am p litude  o f the response versus flash streng th  
(Figure IE). The flash necessary to p ro d u ce  a half-m axim al 
response  was —2,000 tim es b rig h te r in  l . r a f '  rods ( l . r a f ' \
33,000 ±  2,000 photons/|.im"; l . r a f ' \  18 ±  1 photons/|.im"). 
The decreased dark  cu rren t, decreased  sensitivity, and  faster 
response kinetics o f  l .r a f  ' rods w ere all consisten t w ith 
b leaching ad ap ta tio n  p ro d u ced  by residual opsin  activity in  
the absence o f a ch ro m o p h o re  [26-28], This p h eno type  is 
m ore  severe than  tha t o f  Rpe65 ' rods, w hich a re  —150-fold 
less sensitive than  no rm al [16], This may be exp lained  by the 
low er levels o f 9-cm-RAL (see Figure S I) [23] seen in  l .r a f ' 
m ice com pared  w ith Rpe65 ' m ice. The sensitivity o f l .r a f ' 
rods was m arkedly enhanced  w hen the m ice w ere gavaged 
w ith  9-cis-R-Ac. F igure 4C an d  ID show flash fam ilies 
reco rd ed  from  l .r a f '  m ice rods a f te r  a single gavage (Figure 
4C) and  m ultip le  gavages (Figure ID). Figure IE shows the 
co rresp o n d in g  stim ulus-response relations. The dark  c u rre n t 
was res to red  to  n ear-n o rm al levels a f te r  a single tre a tm en t 
w ith 9-cis-R-Ac (15 ±  1 pA, n =  10), and  the half-m axim al flash 
stren g th  was reduced  to  390 ±  20 photons/|.im" (n =  10). 
C o rrec ting  fo r  the — 3-fold reduced  q u an tu m  efficiency from  
rh odopsin  to iso rhodopsin , the sensitivity o f  singly-treated 
rods was —8-fold less than  norm al. T reatm ent w ith m ultip le  
doses o f 9-cis-R-Ac increased  the sensitivity. The half-m axim al 
flash s tren g th  a f te r  th ree  trea tm en ts  was 87 ±  6 photons/|.lm" 
(n =  26). C o rrec ting  fo r  the low ered 9-cis-RAL q u an tu m  
efficiency, this is w ith in  a fa c to r o f two o f W T m ouse rod  
responses.
Restoration of ERG in L ra f / Mice Treated with 9-c/s-R-Ac
ERG re sp o n se s  in  tr e a te d  a n d  c o n tro l l . r a f '  m ice
confirm ed the im provem ents described  above fo r  individual 
ro d  signaling. T he a-wave (generated  by pho to recep to rs) and  
b-wave (generated  by b ip o la r cells) o f d ark -ad ap ted  l .r a f ' 
m ice w ere ab o u t 5 % o f  the am p litude  o f  those observed in 
W T m ice (Figure IF). T he l .r a f ' b-wave was also reduced  
substantially, in  p ro p o r tio n  to  the decreased a-wave. Follow­
ing m ultip le  9-cis-R-Ac gavage trea tm en t, ERG a- and  b-wave 
am plitudes increased  to  ab o u t h a lf o f W T levels (Figure IF 
and  4G).
AAV-Lraf Rescue of Visual Function in Lraf-Deficient Mice
As an  a lternative  to  o ra l gavage, we tested  the ability o f 
tre a tm en t w ith rAAV e a rn in g  the Lrat gene to  res to re  
fu n c tio n  in  /.m i-deficien t mice. Im m unolocalization  o f  LRAT' 
in rA A V -/.ra*-treated l . r a f '  m ouse eyes showed expression  in 
the vicinity o f  the in jec tion  site (Figure 5A) and  was no t 
u n ifo rm  (Figure 5B). H igher reso lu tion  fla t-m oun ted  im m u­
nocytochem istry  showed th a t I.rat was expressed  specifically 
in the RPE o f trea ted  mice, bu t was n o t observed in  con tro l 
m ice (Figure 5C and  5D). T reatm ent led to  p ro d u c tio n  o f 
rh o d o p sin  as d e te rm in ed  by re tin o id  analysis and  iso lation  o f 
rh o d o p sin  (Figure S3). 'The m easurem ents o f the level o f 
rh o d o p sin  as m easured  bo th  directly  by spectroscopy and  
ind irectly  by cis-retinoids (11- o r  9-) a re  in  good ag reem en t 
(see also [29]).
T reatm ent w ith rAAV-l.rat increased  the sensitivity o f the 
a- and  b-waves in  l .r a f '  m ice (Figure 5E and  5F). 'The rescue 
was co m p arab le  to  9-cis-R -A c-treated m ice. T he largest 
im provem ent in  sensitivity was seen 6 wk a f te r  in jec tion  o f 
the virus, while the response  gradually  declined  from  6-31 wk 
p o st-tre a tm en t (Figure 5F). T he im provem en t in a- and  b-
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Figure 4. Rescue of Visual Responses Measured by Single-Cell Recording and ERG Responses of single Lrat1/1 and Lrat"'" Rods 
(A-D) Flash families measured for a Lrat1/1 rod (A), a control Lrat"'" rod (B), a Lrat "'" rod after a single gavage with 9-c/s-R-Ac (C), and a Lrat"1" rod after 
three gavages with 9-c/s-R-Ac (D). Each panel superimposes average responses to five to 20 repeats of a flash, with the flash strength increasing by a 
factor of two for each successively larger response.
(E) Stimulus-response relations for the same cells in (A-D). Maximal response amplitudes are plotted against the flash strength. Fits are saturating 
exponential functions, used to estimate the strength of the flash producing a half-maximal response (Lratiyi, 26 photons/^m2; Lrat"'", 43,000 photons/ 
t^m2; singly treated Lrat"1", 590 photons4im2; and multiply treated Lrat"1", 69 photons/^im2).
(F and G) Comparison of WT mice scotopic single flash ERG to Lrat"'" 9-c/s-R-Ac gavaged mice and Lrat"'" and Lrat1/1 control mice. Lrat"'" mice were 
gavaged nine times with 5 ^mol 9-c/s-R-Ac over a 1-mo time period (n > 3, data shown with SD).
DOI: 10.1371/journal.pmed.0020333.g004
wave sensitiv ity  fo llow ing  rA A V -l.m t  t r e a tm e n t show ed 
considerab le  variability, m ost likely due to  the  in h e ren t 
variability  in the  am o u n t o f  vecto r surgically delivered  to  
these small eyes (Figure S4).
The visual p igm en t o f  rA A V -/.m f-treated /.m i-deficient 
m ice was augm en ted  by oral gavage w ith 9-as-R-Ac as 
described  above. This augm en ta tion  was observed by HPLC 
separa tion  and  quan tifica tion  o f  11-cis-RAL oxim es (a result 
o f  rAAV rescue) and  9-tis-RAL oxim es (Figure S3A-S3C). 
ERG responses in l . r n f ; m ice tre a ted  w ith rA A V -l.rn t and  9- 
cis-R-Ac fu r th e r  im proved  to  reach th e  levels o f  9-ew-R-Ac 
tre a te d  m ice (Figure Sf>I) and  S?>E).
Both rAAV-Lraf and 9-c/s-R-Ac Treatment Restore PLRs in 
Lraf-Deficient Mice
PLRs w ere used to  assay rescue o f re tina l signaling to  the 
b ra in  (Figure 6). R esto ra tion  o f  PLR im plies successful 
transm ission  o f pho tic  in fo rm atio n  to  th e  olivary p re tec tum  
o f  th e  brain . PLR o f  con tro l l . r n f1 m ice w ere ~ 3 .5  log units 
less sensitive th an  heterozygous o r  WT anim als (Figure 61). 
Irrad iance-response  rela tions fo r PLR show ed th a t bo th  9-cis- 
R-A c  and  rA A V -l.rn t trea tm en ts  each increased  l . r n f1 PLR 
sensitivity by —2.5 log units (Figure 61). Figure 6A -6I) and 
V ideo S I com pare  th e  PLRs o f  th e  sam e l.rnf"1 m ouse before  
and  a fte r  9-tis-R-Ac trea tm en t, illu stra ting  th e  significant 
gain in photosensitiv ity  observed follow ing trea tm en t. S im ­
ilarly, Figure 6E -6H  and  V ideo S2 show th a t rA A V-l.rn t 
tre a tm e n t con fe rred  substantially  increased  sensitivity to
light stim uli as com pared  w ith th e  con tro l con tra la te ra l eye 
o f  th e  sam e anim al. S im ilar im proved  PLR w ere recently  
o b ta ined  fo r Rpi’65"1 m ice tre a ted  w ith 9-cis-RAL |?>0|.
Complementarity of Viral and Pharmacological Rescue of 
Lrat~/~ Mice
To d e te rm in e  if viral and  pharm acologic  trea tm en ts  could 
be com bined, we pe rfo rm ed  oral gavage on l . r n f1 m ice 
previously rescued w ith rAAV-l.rnt. B iochem ical augm enta­
tion  o f  visual p igm en t was observed directly, as th e  e lu tion  o f 
11-eu-RAL oxim es (a resu lt o f  AAV rescue) and  9-cis-RAL 
oxim es (p roduced  by oral gavage) w ere well separa ted  on a 
HPLC colum n (Figure S3A-S3C). W hile ERG am plitudes o f 
virally-rescued anim als w ere below those seen in m ice rescued 
by oral gavage, ERG responses in l.rnf"1 m ice tre a ted  with 
rA A V-l.rn t and  9-tis-R-Ac fu r th e r  im proved  to  reach  the 
levels o f  9-tis-R-Ac tre a ted  m ice (Figure SHI) and  S?>E).
Discussion
H ere, we d em o n stra te  th a t in b o rn  e rro rs  o f  m etabolism  
lead ing  to  b lind ing  diseases can be successfully tre a ted  by 
gene therapy  o r  pharm acological in terven tion . Visual p ig ­
m en t fo rm ation , tissue m orphology, and  visual function  as 
m easured  by single-cell recordings, ERG, and  PLR w ere 
significantly im proved  a fte r  tre a tin g  a m ouse m odel o f  LCA 
due to  deficiency in LRAT w ith in trao cu la r in jections o f 
rA A V-l.rn t o r  by oral gavage w ith 9-cis-R-Ac. Pharm acological
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Figure 5. Immunocytochemistry and ERG of rAAV-traf-Treated Lrat ' 
Mice
(A) Immunolocalization of LRAT (green) in rAAV-Lrat treated Lraf~;~ 
mouse eye. Anti-LRAT antibody was directly labeled by Alexa 488. 
Expression of LRAT is locally restricted (arrowheads) in the eye. Nuclei are 
stained by Hoechst 33342 (blue).
(B) Higher-power magnification image of (A). LRAT (green) is observed 
specifically in the RPE cell layer.
(C) Subcellular localization of LRAT in rAAV-Lrat treated LraC;~ mouse 
eye. RPE cells were labeled by anti-LRAT and detected by Cy3-labeled 
secondary antibody (red). Nuclei are stained by Hoechst 33342 (blue). 
RPE cell layer was mounted flat on a coverslip and imaged. LRAT is 
localized in the internal membrane of the RPE cells. Similar localization 
was observed for WT mouse RPE cells [12],
(D) Control flat-mounted RPE cell layer of untreated LraC;~ mouse. Anti- 
LRAT antibody does not show any non-specific labeling. Bars indicate 
100 nm.
(E) Comparison of scotopic single flash ERG of rAAV-Lrat treated, Lrat1/1, 
and Lrar'~ control mice as measured by a-wave amplitudes, (n > 16, 
data shown with SD).
(F) A plot of a-wave amplitudes at 2.8 cd-s-rrT2 intensity as a function of 
post-treatment time for rAAV-Lrat treated mice.
DOI: 10.1371/journal.pmed.0020333.g005
in te rven tions to  tre a t som e form s o f re tina l disease have been 
a ttem p ted  in anim al m odels o f  hum an  b lind ing  conditions, 
am ong  them  trea tm en t o f  rdl m ice w ith the C aJ channel 
b locker /)-«s-diltiazem  and  o th e r  blockers th a t p reven t rise o f 
in trace llu la r C aJ to toxic levels [31], and  tre a tm en t o f  rdl 
m ice w ith leukem ia inh ib ito ry  fac to r, w hich is involved in the 
dow n-regulation  o f  genes involved in synthesis and  deg rada­
tion  o f  cCtMP [32], O th e r  studies have used in h ib ito rs  o f 
apaptosis, an ap p roach  applicab le  to a wide range o f re tina l 
d isorders. Several studies suggest th a t in trao cu la r in jection  o f 
n e u ro tro p h ic  factors (e.g., b ra in -derived  n e u ro tro p h ic  fac to r
and  ciliary n eu ro tro p ic  fac to r ) can p ro tec t the m urine  re tin a  
from  light dam age, o r  delay p h o to re c e p to r  d eg enera tion  in 
anim al m odels (for exam ple [33]). In m ost cases, the beneficial 
effects o f  tre a tm en t last less than  a m on th  and  req u ire  
rep ea ted  adm in istra tions.
Dryja and  colleagues show ed th a t ROL su pp lem en ta tion  
slows the ra te  o f  p h o to re c e p to r  d eg en era tio n  caused by a 
T4M rh odopsin  m u ta tio n  in m ice [34]. M ore recently , fl-eis- 
RAI, app lica tion  to  11 pro ^  m ice resu lted  in fo rm ation  o f an 
active iso-rhodopsin  and  an im provem ent in the KRG o f these 
anim als fo r a tim e p e rio d  o f up  to fi m o a f te r  tre a tm en t [7,lfi], 
The Rpe65 m u ta tio n  blocks the re tin o id  cycle by p reven ting  
the genera tion  o f 11-m-RAL, the ch ro m o p h o re  o f  visual 
p igm ents. O ral app lica tion  o f  9-ds-RAI, circum vents this 
blockage. The blockade has also been rescued  by r , \ \ 7\ 7-Rpe65 
gene tra n sfe r m eth o d  in naturally  /i’/;«65-deficient dogs [?)]. 
Ilpr m ice display enhanced  esterification  p ro p e rtie s  tha t 
could  lead  to  trap p in g  fl-cis-retinoids in the form  o f  fl-eis-RKs. 
T hus it was very im p o rtan t to  exam ine if this ph a rm aco ­
logical app roach  w ould be successful in m ice lacking the key 
esterify ing enzyme. C om bin ing  oral re tin o id  tre a tm en t (using 
nex t-g en era tio n  re tin o id  pro -d rugs) and  viral rAAV-Lral 
som atic gene therapy  in L r a f1 m ice led to  rem arkable  
rescue o f visual functions in these mice. We found  th a t both 
m ethods increased  KRG responses from  ~ 5 %  o f w ild-type 
levels in L r a f1 m ice to  ~ 50%  o f w ild-type levels in trea ted  
L r a f1 m ice. R etino id  trea tm en t led to  increased  levels o f 
visual ch ro m o p h o re  from  u n de tec tab le  levels to fiOO pinoles 
p e r  eye. The ROS dark  c u rre n t was re s to red  to  near-no rm al 
levels o f 15 ±  1 pA a fte r  a single tre a tm en t w ith fl-cis-R-Ac, 
and  the half-m axim al flash streng th  a fte r  th ree  trea tm en ts  
was 87 ±  fi pho tons/|.in r. C o rrec ting  fo r the low ered 9-cis- 
RAL q uan tum  efficiency, this is w ithin a fa c to r o f 2 o f  WT 
m ouse ro d  responses. Irrad iance-response  rela tions fo r PLR 
show ed th a t both  9-cis-R-Ac and  rAAV-Lral trea tm en ts  each 
increased  L r a f1 PLR sensitivity by ~ 2 .5  log units.
Rescue of Visual Functions by Pharmacological Treatment 
and Gene Transfer
O u r previous findings described  the L r a f1 m ouse as a 
m odel o f  LCA w ith patho log ical characteristics sim ilar to 
those found  in p a tien ts  affected  by m u ta tions in the LRA F 
gene [11], In the c u rre n t study, we dem o n s tra te  th a t visual 
functions can be rescued  in L r a f1 m ice, as m easured  by 
recovery o f visual ch ro m o p h o re  and  p igm ent, and  by single­
cell and  KRG responses. Successful re s to ra tio n  o f  re tino tec ta l 
signaling, as m easu red  by pup illary  responses, was also 
achieved. Pharm acological tre a tm en t was successful in every 
experim en ta l trial, w ith re s to ra tio n  o f abou t half-m axim al 
KRG responses com pared  w ith the W I’ mice. W hile full 
re s titu tio n  o f  the KRG could  no t be ob ta in ed  in L r a f1 m ice 
in the tested  experim en ta l conditions, o u r  find ing  o f nearly  
com plete  re s titu tio n  o f  single cell responses suggests tha t 
rem odeling  o f  the neu ro n a l re tin a  in L r a f1 may lim it 
functional rescue [35], Possibly, the ROS o f L r a f ; m ice are 
sh o r te r  as a resu lt o f dam age caused by p h o to tran sd u e tio n  
triggered  by free opsin  [27,28], a ph en o m en o n  rem in iscen t o f 
ROS shrinkage u n d e r  con tinuous stim ula tion  by light (pho to ­
stasis) o r  as a resu lt o f  v itam in  A d ep riva tion  [3fi-38], 
H owever, the ro d  p h o to recep to rs  resist com plete  deg en er­
ation  in L r a f1 m ice (even in 17-m o-old m ice raised  in a 
norm al light cycle), while the cones undergo  alm ost com plete
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degenera tion . In fact, th e  ROS in 17-m o-old m ice a re  nearly  
as long as in  2-m o-old L rar'~  m ice (see F igure S2B). A sim ilar 
observation  has been  m ade fo r /i/>c-65-deficent m ice [39], 
M ultiple gavages d u rin g  a 2-wk p e rio d  led to  m orpholog ical 
re s to ra tio n  once  th e  ROS co m ple ted  th e  12-d cycle o f 
phagocytosis and  renew al [24]. The im proved  rescue a fte r  
m u ltip le  gavages was confirm ed  n o t only by re tin o id  analysis 
by HPLC, b u t also by m orphological analysis and  elec tro - 
physiological tests. In single-cell record ings, th e  —3-foId 
d ifference  in sensitivity betw een W l’ ROS and  ROS from  
m ultip ly  tre a te d  L r a t T m ice could  be accoun ted  fo r  by the 
discrepancy in th e  q u an tum  yield o f  opsin loaded with 1 l-cis- 
RAL and  9-cis-RAL eh rom ophores. These d ifferences are 
small com pared  to  the  range o f  in tensities over which vision 
opera tes  [40],
O ral synthetic re tin o id  tre a tm en t was rem arkably  success­
ful in rescu ing  th e  Lrar'~  p h eno type  because o f  the  highly 
specific m echanism  o f  ROL tra n sp o rt and  re te n tio n  [41], 
ROL ab so rp tio n  is follow ed by en tra p m e n t o f  REs in th e  lipid 
d rop le ts  o f  hepatic  stella te  cells and  th e  re tinosom e stru c ­
tu res found  in the  RPE [12,42]. ROL is m obilized  from  the 
in testin e  o r  liver as ROL e s te r co m ponen ts  o f  chylom icrons 
o r  as ROL com plexed  with R O L -binding p ro te in  and  tra n s­
thy re tin  o r  album in  [12,42—44]. C is-retinoids em ployed in this 
study used th e  existing  re tin o id  tra n sp o rt system and  w ere 
efficiently delivered  to  th e  eye (see F igure 2C).
W e have chosen 9-cis-retinoids in o u r  studies because they 
display h ig h er stability  th an  1 1-cis-retinoids in storage and  
hand ling  and  at th e  low pH  o f  th e  stom ach, and  they req u ire  
sim pler chem ical synthesis, yet they share m any advantages o f
1 1-cis-retinoids, includ ing  th e  efficient fo rm atio n  o f  highly 
sensitive p igm en ts an d  a s im ila r m etabo lic  pathw ay o f 
d eg rada tion  and  tra n sp o rt in m am m als. Based on  th e ir  
chem ical p ropertie s , p ro -d ru g  cis-REs ap p e a r  to  be a b e tte r  
a lte rna tive  to  RAL o r  ROL because o f  th e ir  stability and 
efficient m etabolic tran sfo rm atio n  to  active 9-cis-RAL in the 
eye. Interestingly, o th e r  p ro-drugs, such as v itam in E, a re  also 
delivered  as m ore  hydrophilic  succinate  esters [45]. Such REs 
low er th e  hydrophob ic ity  and  non-specific d iffusion o f  these 
lip id -so lub le  c o m p o u n d s  w ith in  th e  m em b ran es  o f  th e  
d igestive trac t. In the  RPE, 9-cis-ROL is transien tly  trap p ed  
as REs ( Table 1), which then  undergo  hydrolysis and  ox idation  
to  reg en e ra te  th e  active ch ro m o p h o re  9-cis-RAL (see Figure 
1C). The abso rp tion  and  tran sfo rm atio n  o f  cis-retinoids m ight 
be sim ilar to  th a t o f  a ll-/ra« i-retino ids because o f  th e  m ultip le  
overlapp ing  activities o f  the  enzym es involved and  th e ir  low 
specificity tow ard  d iffe ren t re tin o id  isom ers [41],
Viral tre a tm en t was also effective in res to rin g  th e  norm al 
re tin o id  cycle in th e  eye and  rescu ing  visual function . The 
rescu e  peaked  at 6 wk and  th en  slowly decayed. The 
expression  o f  Lrat was localized to th e  in jec tion  site, bu t 
significant rescue o f  visual p igm en t rh odopsin  was observed 
(—50%). M ore eye-to-eye variability  was observed with viral 
rescue th an  w ith pharm acologic  rescue. Because o f  th e ir  small 
size and  relatively large lenses, which occupy abou t 70% o f 
th e  eye, subre tina l in jection  surgery is m o re  com plica ted  fo r 
m ouse eyes th an  it w ould be fo r  la rg er eyes.
W hile d irec t com parison  o f  rescue m ethods is difficult, it 
appears  th a t bo th  th e rap eu tic  m ethods p rov ide efficient 
recovery o f  h ig h er o rd e r  visual responses, as tested  by PLRs. 
The c lea r advantage o f oral re tin o id  tre a tm en t is its ease o f 
ad m in is tra tio n  co m p ared  w ith th e  su b re tin a l in jec tions
Figure 6. Light-Induced Pupillary Constriction of Lrat ' Mice Before and 
After Treatment with 9-cis-R-Ac or rAAV-Lrat
(A-H) 470 nm light (4.79 X 1013 photons-cm 2-sec ’) was used to 
stimulate pupillary constriction. Untreated Lrat ' pupil before (A) and 
during (B) light exposure. Same mouse as in (A and B) subsequent to 
treatment with 9-cis-R-Ac, before (C) and during (D) light exposure. 
Control, untreated pupil of Lrat' mouse before (E) and during (F) light 
exposure. Contralateral eye of mouse shown in (E and F) treated with 
rAA V-Lrat, before (G) and during (H) light exposure.
(I) Irradiance-response relations for PLR to 470 nm light.
DOI: 10.1371/journal.pmed.0020333.g006
req u ired  fo r  viral vectors. Its p rim ary  d isadvantage is its 
p o ten tia l fo r  long-term  systemic toxicity  com pared  to  vec to r 
ta rg e tin g  o f  LRAT to the  RPE. The usual advantage o f  rAAV- 
delivered  gene therapy  over systemic drugs is th e  persistence  
o f  passenger gene expression a fte r  a single adm in is tra tion ; 
how ever, in th is case th e re  was a gradual b u t d is tinc t loss o f  
delivered  LRAT fu n c tio n  a f te r  several m onths. This has no t 
been  observed in o th e r  systems (RPE65 dog and  m ouse 
studies) and  may reflect an Lrar '~ -specific effect on RPE 
viability. The slow and  gradual decline in ERG am plitude  in 
tre a te d  m ice is also observed w ith age in Lrat f m ice. 
A lthough th e  decline ra te  d u rin g  th e  first 7 m o o f  life fo r 
Lrat m ice is slight (T. M aeda and  KP, unpub lished  data) and 
is slow er than  in rA A V -treated  mice, th e  d irec t com parison  is 
n o t precise, as u n tre a te d  re tin as  o f  L r a f d egenera te  slowly, 
and  th e  level o f  opsin expression  appears  to  be slightly low er 
(unpub lished  data). Thus, th e  observed decline  in ERG 
am plitudes could be a resu lt o f  several d iffe ren t factors, 
includ ing  th e  stability o f  rAAV infection , re tin a  rem odeling  
in Lrar'~  m ice [35], and  sh o r te r  ROS s tru c tu re  in L r a f m ice 
(th is study) an d  d e g e n e ra tio n  o f  cone  p h o to re c e p to r s
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(unpublished  data). Im portan tly , 9-cis-R-Ac trea tm en t ap ­
p ea red  to  im prove rescue in virally tre a te d  anim als, and  
resu lted  in reco n stitu tio n  o f  both  native I l-cis-retinoids and  
ad m in is te red  9-cis-retinoids sim ultaneously.
Insight into Retinoid Metabolism
The level o f 9-e*s-RAI, is m ain ta in ed  in th e  eyes o f 9-e*s-R- 
A c-trea ted  L r a t T d ark -ad ap ted  m ice fo r  over 4 mo. This 
find ing  suggests th a t th e  rod-RPK system efficiently recycles 
th e  c h ro m o p h o re  o f  phagocy tosed  visual p igm en t. This 
p h en o m en o n  can be readily observed, because re tino id s are  
only tran sien tly  s to red  in o rgans o th e r  th an  th e  eye in LratT 
m ice. A pproxim ately  10% o f th e  ROS is renew ed each day 
14G |. The en tire  length o f  th e  ROS is thus com pletely  renew ed 
in less th an  2 wk. However, th e  9-cis-RAI, based p igm en t 
persists in th e  eye fo r 4 m o post-gavage a t a ~ 5 0 %  level. This 
can be exp la ined  only by th e  recovery o f  9-cis-chrom ophore 
from  iso rhodopsin  phagocytosed by the  R P L  Second, even 
though  RKs are  tran sien tly  fo rm ed  in th e  eye ( Table 1), they 
do n o t su p p o rt th e  re tin o id  cycle, suggesting th a t LRAT is a 
key enzym e in this process and  th a t fo rm ation  o f  esters is 
insufficient in the  com pletion  o f  th e  cycle. This observation  
suggests th a t localization o f  these esters is crucial fo r  the 
p ro p e r  func tion  o f  th e  re tin o id  cycle. Third, we confirm ed 
rep o rts  ob ta in ed  by Fan e t al. |23 | th a t m ice w ith an im paired  
re tin o id  cycle a p p e a r  to spon taneously  genera te  9-e*s-RAI, 
th a t is th en  tra p p e d  by ROS co n ta in in g  alm ost exclusively 
free  opsin.
Leber Congenital Amaurosis and Potential Treatment
The m ajo r advantage o f  re tino id -based  trea tm en ts  o f  LCA 
re s u ltin g  fro m  th e  d e fic iency  o f  IJRAT is th a t  th ese  
com pounds a re  no t s to red  in the  liver fo r any p ro longed  
tim e  a n d  a re  quick ly  o x id ized  a n d  secre ted . R e tin o id  
ab so rp tio n  in m am m als is an active process driven  by 
esterification/hydrolysis cycles in th e  in testine  and  liver and  
in th e  R PL  Fsterification is ca rried  o u t m ainly by LRAT |47|, 
as evidenced  by th e  fact th a t th e  absence o f LRAT makes 
re tino id s vu lnerab le  to  quick elim ination  from  th e  body. In 
th e  absence o f LRAT, th e  equ ilib rium  betw een ROI.s and  RKs 
is clearly sh ifted  in favor o f free  ROL. Low levels o f  RKs are 
p resen t in m ice defic ien t in LRAT expression (LratT^ ), bu t 
these esters a re  fo rm ed  transien tly  as a possible consequence 
o f  acyI-CoA:retinoI acy ltransferase activity |25, 48|.
An im p o rtan t find ing  is th a t th e  pharm acological tr e a t­
m en t can be sustained  m u ltip le  tim es, and  th a t several low- 
dose trea tm en ts  show cum ulative effects. This tre a tm en t is 
possible at any age, as th e  m orpholog ical s tru c tu re  o f  the 
re tin a  is to  som e degree  p reserved  in bo th  young  and  old 
m ice. These d a ta  a re  re m in isc e n t o f  re su lts  o b ta in e d  
follow ing gene therapy  o f RPE65-deficient m ice and  dogs 
|7 ,9 ,12,16,49,50|.
Cis- and  alMraris-RALs a re  irreversibly oxidized to RAs by 
RAI, dehydrogenase types 1, 2, 3, and  4 |51 |. AIMrrms-RA and  
its 9-cis-isom er are  im p o rtan t regu lato rs o f  gene expression 
via n uc lea r recep to rs  |52 |. F o r any re tino id -based  therapy  
th e re  can be negative side effects resu lting  from  p o ten tia l 
p ro d u c tio n  o f  RAs and  th e ir  te ra togen ic  effects. To p reven t 
th e ir  accum ulation , RAs a re  oxidized by CYP26A1, CYP26B1, 
and  CYP26C1 to 4-hydroxy-RA, 4-oxo-RA, and  18-hydroxy- 
RA 1531. As dem o n s tra ted  here, only a low and  tran s ien t level 
o f  RAs is observed in th e  L r a t T m ice gavaged w ith 9-e*s-R-Ac,
argu ing  th a t th e  po ten tia l side effects due  to RA p ro d u c tio n  
a re  highly a tten u a ted . M ore toxicological studies are  needed  
befo re  pharm aco log ica l tre a tm e n t can be p ro p o sed  fo r 
tre a tm en t o f sim ilar hum an conditions. It is possible th a t a 
com bination  o f  viral and  pharm acological tre a tm en t could  be 
the  m ost efficient m eans o f  res to rin g  vision in patien ts 
afflicted w ith LCA, fo r  w hom  no tre a tm e n t is cu rren tly  
available.
The rescue o f  PLRs in Lrar'~  d em onstra tes  th a t tre a tm en t 
o f  the  re tina l defects results in u ltim ate  im provem ent in 
signaling from  eye to  brain . PLRs a re  m ed ia ted  by both  in n e r 
re tinal, non-visual p h o to recep to rs  j54 1 and  ro d  and  cone 
inpu t. W hile m easu rem en t o f  th e  PLR in this study could  no t 
readily d istinguish  betw een rescue o f  in n e r  and  o u te r  retinal 
ph o to recep to rs , given the  observed d ram atic  im provem en t o f  
the  FRG, these results suggest th a t rescued o u te r  retinal 
func tion  m ay be at least partly  responsib le  fo r rescue o f  the 
PLR. D ete rm ina tion  o f  th e  ex ten t to  w hich pharm acologic  o r  
som atic gene therapy  rescue o f  LratT^  m ice w ould allow 
res to ra tio n  o f  actual visual func tion  will req u ire  additional 
study. It is unknow n a t p re sen t to  w hat ex ten t m ice lacking 
Lrat develop norm al in tra re tin a] circuitry , and  it is sim ilarly 
unknow n to w hat ex ten t these m ice develop am blyopia from  
visual deprivation . The a p p a re n t visual im provem en t asso­
c iated  w ith rAAV rescue in dogs m u tan t in th eH pe65  gene |9 |, 
however, does suggest th a t fo rm  vision may be re s to red  in at 
least som e form s o f  LCA.
O u r findings establish th a t both  ch ro m o p h o re  su pp lem en­
ta tio n  and  som atic gene therapy  a re  effective in im proving  
visual functions in the  LratT^  m ouse, an anim al m odel o f  LCA 
th a t accurately  rep licates th e  pathology o f  th e  disease. The 
trea tm en ts  a re  optim ally  effective in com b ina tion  and  if the 
ch ro m o p h o re  su pp lem en ta tion  is co n tin u ed  at low doses fo r 
a longer p e rio d  o f  tim e. A pplying 9-cis-R-Ac tre a tm e n t to  
virally tre a te d  anim als ap p ea red  to im prove rescue, and  
resu lted  in reco n s titu tio n  o f  bo th  native 1 I-cis- and  adm in ­
is tered  9-cis- re tino id s sim ultaneously. There is a g reat value 
in com bined  approaches, fo r several reasons. First, e ith e r one 
may prove to  be m ore  su itab le  fo r  a specific age g roup  o f  
pa tien ts , thus offering  effective tre a tm en t fo r  a w ider age 
range; second, a p artia l and  regional rescue by rAVV, as 
observed in th e  ii/M '65-deficient dog (unpublished  data), could 
be augm en ted  by re tin o id  trea tm en t, reach ing  th e  w hole 
re tina ; th ird , th e  rescue in rA V V -treated  anim als allows 
sto rage o f  9-cis-RKs th a t m ight be m obilized  w hen needed  (for 
exam ple, high b leaching levels). C linically, it is likely th a t 
pharm acologic  and  som atic gene th e rap eu tic  approaches, if 
successful, cou ld  be used in com plem en tary  fashion; fo r 
exam p le , t r e a tm e n t o f  a p p ro p r ia te  p a tie n ts  w ith  o ra l 
re tino ids cou ld  begin in infancy to  avoid am blyopia, avoiding 
the  difficulties associated  w ith surgery  in very young  patien ts, 
w hile a t o ld er ages long-lasting d rug-free  tre a tm en t m ight be 
achieved by surgical in tro d u c tio n  o f  viral vectors.
This w ork on the  rescue o f  vision ex tends prev ious studies 
by V an H ooser et al. j7,1GJ in p a r t by em ploying novel 
com pounds w ith po ten tia lly  b e tte r  d rug-like p ro p ertie s , and  
to th e  second  LCA m ouse m odel. In co n tra st to  Kpe65~'~ mice, 
LratT^  m ice do n o t have significant capacity  to  s to re  re tino ids 
ou ts ide  o f  th e  visual p igm ent; however, th e  pharm acological 
app ro ach  was highly successful. There have been rep o rts  
d o cum en ting  th e  p o ten tia l adverse effects o f high doses o f  
re tino ids j5 5 1. D uring  these and  re la ted  studies o f  bo th  acu te
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and  p ro longed  (up to  1 y) m ultip le  dose trea tm en ts , no 
adverse effects w ere observed fo r m ice o f  several genetic 
backgrounds. N um ber and  size o f litters, coat groom ing, 
survival a fte r  gavage, post-nata l developm ent, and  grow th/ 
w eight curves w ere unaffected  by trea tm en t, l . r n f1 m ice may 
be particu larly  resistan t to  p o ten tia l toxicity  o f RK com ­
pounds, as lack o f  esterification  o f th e  re tin o id  agents actively 
leads to  rap id  rem oval th rough  secretion  and  ox idation  to  
oxo/hydroxo RA com pounds. This reac tion  occurs n o t only in 
th e  eye b u t also in the  liver, w here LRA T is also norm ally 
expressed. The tran s ien t fo rm ation  and  accum ulation  o f 
re tin o id s  observed  in these  m ice soon  a f te r  tre a tm e n t 
d isappeared  w ith in  a day in m ost cases. O nly visual p igm ents 
had  th e  capability  to  re ta in  these re tino id s fo r  a long p e riod  
o f  tim e, as shown in F igure 2H. These observations raise the 
h o p e  tha t, a fte r  form al toxicological studies, these RK p ro ­
d rugs have th e  p o ten tia l to  be ex ten d ed  effectively to 
hum ans.
Supporting Information
Figure SI. Chromatographic Separation of Retinoids Extracted from
16 L ra f1- Mouse Eyes
(A) Peak 1, syn-1 1-cis-RAL oxime; 2, undetermined compound with 
Amax at 315 nm; 3, syn-all-trans-RAL oxime; 4, syn-9-cis-RAL oxime; 5, 
13-cis-ROL; and 6, all-trans-ROL.
(B) Retinoids bound to im mu no affinity purified opsin from 40 
untreated L ra f /- mouse eyes (one-third of the sample was loaded on 
the HPLC column).
Found at DOI: 10.1371/journal.pmed.0020333.sgOOl (125 KB PDF).
Figure S2. Levels of 9-cis-RAL in Mice of Different Ages Treated with 
9-cis-R-Ac
(A) 9-cis-RAL oxime levels in Lra f l- mouse eyes following gavage with 
20 jimol 9-cis-R-Ac at differing ages. The analysis is performed after 
72 h of post-gavage dark adaptation (n > 3).
(B) ROS thickness as a function of the retinal location from the optic 
nerve head (in mm). Four age-matched retinas of WT and L ra f1- were 
analyzed both in inferior/superior and nasal/temporal orientations, 
and the data plotted with Microsoft Excel. The dotted lines represent 
data from 2-mo-old Lrat*1- and L ra f1- mice as published earlier [10]. 
Found at DOI: 10.1371/journal.pmed.0020333.sg002 (60 KB PDF).
Figure S3. Retinoid Analysis and ERG of rAA V-Lral Treated L ra f1- 
Mice Augmented with 9-cis-R-Ac
(A) L ra f/- mouse treated with rAAV-Lrat Inset, i mm u no affinity- 
purified rhodopsin from the retina of L ra f1- mice treated with rAAV- 
Lrat virus. E, corresponding fraction in elution.
(B) L ra f1- mouse treated with 9-cis-R-Ac.
(C) L ra f1- mouse treated with rAA V-Lral and 9-cis-R-Ac. Peaks 
marked * represent the solvent change artifact. Inset, the chromato­
gram of retinoids from WT mouse.
(D) Sco topic single-flash ERG a-waves.
(E) Sco topic single-flash ERG b-waves (n > 10 , data shown with SEM). 
Found at DOI: 10.137l/journal.pmed.0020333.sg003 (175 KB PDF).
Figure S4. Scatter Plot of a- and b-waves of ERGs Obtained from 
rAAV'-Lral-Treated and Control Lra f /- Mice
(A) ERG a-waves of 6- to 7-wk-old Lra f /- control mice.
(B) ERG b-waves of 6- to 7- wk-old L ra fl- control mice.
(C) ERG a-waves of 6- to 7- wk-old rAAV-Lrat-treated mice.
(D) ERG b-waves of 6- to 7- wk-old rAAV-Lrat-treated mice (n > 39).
Found at DOI: 10.1371/journal.pmed.0020333.sg004 (129 KB PDF). 
Video SI. Effect of 9-cis-R-Ac Treatment on the PLR of L ra f1- Mice
PLRs of an individual L ra f1- mouse (left eye) recorded prior (control) 
and 72 h subsequent (9-cis-R-Ac) to three 5-|imol doses of 9-cis-R-Ac. 
Presence of light stimulus (30-s pulse of narrow bandpass 470 nm 
light, 1.38 X 10 4 photons-cm-2 •sec-1) is represented in the movie by a 
light bulb symbol.
Found at DOI: 10.137l/journal.pmed.0020333.sv001 (3.0 MB MOV).
Video S2. Effect of Intraocular Injection of rAA V-Lral on the PLR of 
L ra f1-  Mice
PLRs of an individual Lra f 1- mouse recorded from rAAV-Lrat-t reated 
left eye ( rAAV-Lral) and non-t reated right eye (con t rol). Presen ce of 
light stimulus (30-s pulse of narrow bandpass 470 nm light, 4.79 X 1013 
photons-cm-2•sec-1) is represented in the movie by a light bulb 
symbol.
Found at DOI: 10.137l/journal.pmed.0020333.sv002 (3.0 MB MOV). 
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Patient Summary
Background Some causes of blindness are inherited. Leber congenital 
amaurosis is one inherited disease that causes degeneration and loss of 
activity of the retina—the tissue at the back of the eye. Hence, babies 
have a severe loss of vision at birth as well as roving eye movements 
(nystagmus), deep-set eyes, and sensitivity to bright light. One cause of 
Leber congenital amaurosis is loss of an enzyme called lecithin:retinol 
acyl transferase (LRAT), which is required for regeneration of a pigment 
necessary for the eye to detect light. Currently there is no treatment for 
this condition.
Why Was This Study Done? There are animal models of this disease, 
and previous work has suggested that there are two possible ways of 
treating this condition. One is by giving by mouth synthetic pigments 
similar to those in the eye. Another is by gene therapy with viruses that 
replace the abnormal gene with normal copies. The authors wanted to 
test these methods in a mouse model, and see if the two approaches 
worked well together.
What Did the Researchers Do and Find? They treated mice that had a 
genetic defect mimicking the human condition by placing a virus 
carrying the normal gene directly into their eyes. They also gave the mice 
pro-drugs (compounds that are turned into the active drug inside the 
body) by mouth, which bypassed the missing step in the regeneration of 
the retinal compound. The authors found that they got the best results 
either using individual methods or when they tried both approaches 
together. They could show that the mice had the electrical impulses that 
are a sign that the eye is working correctly, and in addition, their pupils 
responded to light.
What Do These Findings Mean? These results are an early step to 
making these treatments available to patients. Obviously, they would 
only help patients who had this particular genetic defect, and possible 
defects in genes from this same metabolic pathway. Before these 
treatments were to be used, many other questions would need to be 
answered, including whether these oral compounds might be toxic if 
given repeatedly—as they would need to be. Also, acceptable methods 
of placing the gene therapy into human eyes would need to be found.
Where Can I Get More Information Online? The Foundation Fighting 
Blindness funds research on retinal degenerative diseases, and has a 
number of pages of information for patients and families: 
http://www.blindness.org/
Contact a Family is a UK charity that has information on specific
conditions and rare disorders:
http://www.cafamily.org.uk
MedlinePlus also has a series of pages on retinal disorders: 
http://www.nlm.nih.gov/medlineplus/retinaldisorders.html
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